Albert Einstein College of Medicine
Leading expert in neurotoxicology, specializing in metal neurotoxicity, methylmercury research, pesticide toxicity and other environmental agents. Recognized expert in neurodevelopmental and neurodegenerative diseases.
A distinguished leader in neurotoxicology research
Dr. Michael Aschner is a world-renowned expert in neurotoxicology and molecular pharmacology, serving as the Harold and Muriel Block Chair in Molecular Pharmacology at the Albert Einstein College of Medicine.
Dr. Aschner's research centers on understanding the molecular mechanisms underlying metal neurotoxicity, with particular emphasis on methylmercury and manganese toxicity, as well as pesticides and other environmental agents. Expert in gene x environment interactions in affecting neurodevelopment and neurodegeneration.
As President of the Society of Toxicology (2022-2023) and recipient of the prestigious 2010 Society of Toxicology Merit Award, Dr. Aschner has demonstrated exceptional leadership in the field of toxicology. Expert reviewer for multiple Federal Agencies (US EPA, ATSDR, CDC, NIH, EFSA) in the US and abroad. Has served as Chair of the NIH study section ALTOX3. Co-founder of the Series Advancements in Neurotoxicology, associate editor of multiple high impact factor journals.
His groundbreaking research on blood-brain barrier transport mechanisms has significant implications for understanding neurological diseases and developing targeted therapeutic interventions.
Pioneering research in neurotoxicology and molecular pharmacology
Leading research on mercury and methylmercury neurotoxicity, including developmental effects, autism research connections, and neurological impacts. Expert testimony for mercury exposure cases and vaccine-related litigation.
Leading expert on manganese neurotoxicity, providing scientific analysis for manganese exposure cases, occupational manganese poisoning, and welding fume litigation.
Studying metal transport across the blood-brain barrier and its role in neurodegenerative diseases.
Understanding cellular and molecular mechanisms of neurotoxic substances and potential therapeutic interventions.
Expert analysis of pesticide neurotoxicity, environmental contaminants, and gene-environment interactions in neurological diseases. Extensive experience in pesticide litigation and regulatory consultation.
Over 1100 peer-reviewed publications with significant impact
Peer-Reviewed Papers
Total Citations
H-Index
Environmental Health Perspectives (2023)
View PublicationJournal of Biological Chemistry (2012)
View PublicationComprehensive knowledge for legal cases and regulatory consultation
Expert consultation in neurotoxicology and molecular pharmacology
Expert guidance on neurotoxicology research design, methodology, and data interpretation.
Leading neurotoxicology expert witness providing testimony for mefloquine (Lariam) trials, manganese exposure cases, pesticide litigation, mercury toxicity, and trichloroethylene cases. Extensive experience in neurotoxicology consulting for legal proceedings.
Expert neurotoxicology consulting for pharmaceutical and chemical industries. Specializing in manganese exposure assessment, pesticide neurotoxicity evaluation, and mefloquine safety analysis.
Professional training and educational programs in neurotoxicology and molecular pharmacology.
Distinguished achievements in toxicology and neuroscience
Served as President of the premier international organization dedicated to toxicology, representing over 8,000 scientists worldwide.
The highest honor bestowed by the Society of Toxicology, recognizing outstanding contributions to the field of toxicology.
Endowed chair position in Molecular Pharmacology at Albert Einstein College of Medicine.
Serves on editorial boards of multiple prestigious journals in toxicology and neuroscience.
Get in touch for consultation and collaboration opportunities
Albert Einstein College of Medicine
Department of Molecular Pharmacology